申请人:A. Nattermann & Cie GMBH
公开号:US04460598A1
公开(公告)日:1984-07-17
The invention relates to new triphenylimidazolyloxyalkanoic acids of the general formula I ##STR1## and a process for the treatment of thromboembolic, inflammatory and/or atherosclerotic diseases in humans by using the same.
这项发明涉及一种新的三苯基咪唑氧烷酸,其通式为I,并提供了一种治疗人类血栓栓塞、炎症和/或动脉粥样硬化疾病的方法。